99-11446. Manufacturer of Controlled Substances; Notice of Registration  

  • [Federal Register Volume 64, Number 88 (Friday, May 7, 1999)]
    [Notices]
    [Page 24678]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-11446]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Registration
    
        By Notice dated December 2, 1998, and published in the Federal 
    Register on December 11, 1998, (63 FR 68473), Cauldron Inc., DBA 
    Cauldron Process Chemistry, 383 Phoenixville Pike, Malvern, 
    Pennsylvania 19355, made application by renewal to the Drug Enforcement 
    Administration (DEA) to be registered as a bulk manufacturer of 
    amphetamine, a basic class of controlled substance listed in Schedule 
    II.
        The firm plans to bulk manufacture amphetamine for the purpose of 
    performing bioequivalency studies.
        DEA has considered the factors in Title 21, United States Code, 
    Section 823(a) and determined that the registration of Cauldron Inc. to 
    manufacture the listed controlled substance is consistent with the 
    public interest at this time. DEA has investigated the firm on a 
    regular basis to ensure that the company's continued registration is 
    consistent with the public interest. These investigations have included 
    inspection and testing of the company's physical security systems, 
    audits of the company's records, verification of the company's 
    compliance with state and local laws, and a review of the company's 
    background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
    0.100 and 0.104, the Deputy Assistant Administrator, Office of 
    Diversion Control, hereby orders that the application submitted by the 
    above firm for registration as a bulk manufacturer of the basic class 
    of controlled substance listed above is granted.
    
        Dated: April 26, 1999.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 99-11446 Filed 5-6-99; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
05/07/1999
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
99-11446
Pages:
24678-24678 (1 pages)
PDF File:
99-11446.pdf